Hau T Nguyen, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A80220 · Current
Licensed to practise in California · since 2002 · expires 2028-02-29 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$45,070
Medicare paid this office $45,070 for 211 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 24 | $14,571 | $486 |
| Established patient problem focused exam of visual system | 137 | $9,629 | $38 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 12 | $4,615 | $243 |
| Established patient complete exam of visual system | 31 | $1,693 | $55 |
| Imaging of optic nerve | 58 | $1,020 | $16 |
See all 9 services
| Removal of cataract with insertion of prosthetic lens | 24 | $14,571 | $486 |
| Established patient problem focused exam of visual system | 137 | $9,629 | $38 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 12 | $4,615 | $243 |
| Established patient complete exam of visual system | 31 | $1,693 | $55 |
| Imaging of optic nerve | 58 | $1,020 | $16 |
| Exam of the internal drainage system of eye | 30 | $611 | $16 |
| Exam of visual field with extended testing | 27 | $553 | $19 |
| Ultrasound scan to determine eye length and lens power | 18 | $380 | $18 |
| Imaging of retina | 16 | $373 | $22 |
Procedures Medicare counted
| Cataract surgery | 38 | More than 58% of doctors who do this |
Who their Medicare patients are
211 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 10% · Women 62% · Also on Medicaid 78% · Health risk score 1.32. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 74% · Diabetes 59% · Chronic kidney disease 19% · Coronary heart disease 14% · Heart failure 13% · Cancer 12% · Atrial fibrillation 9% · Depression 9% · COPD 8% · Stroke 6%.
The office billed $652,951, Medicare allowed $64,275 and paid $45,070; for 560 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 211 | 560 | 74 | 1.32 | $652,951 | $45,070 |
| 2023 | 232 | 745 | 74 | 1.46 | $753,284 | $55,703 |
| 2022 | 255 | 823 | 73 | 1.43 | $803,167 | $58,779 |
| 2021 | 231 | 672 | 73 | 1.31 | $765,956 | $57,073 |
| 2020 | 233 | 619 | 72 | 1.59 | $461,762 | $35,867 |
| 2019 | 301 | 903 | 72 | 1.39 | $662,965 | $61,966 |
| 2018 | 325 | 1,033 | 72 | 1.41 | $657,563 | $64,061 |
| 2017 | 337 | 1,014 | 71 | 1.34 | $770,149 | $85,119 |
| 2016 | 330 | 1,046 | 71 | 1.45 | $540,200 | $52,730 |
| 2015 | 258 | 568 | 72 | 1.50 | $557,658 | $51,442 |
| 2014 | 246 | 483 | 72 | 1.28 | $453,843 | $45,503 |
| 2013 | 491 | 1,389 | 71 | 1.30 | $844,461 | $96,365 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal of cataract with insertion of prosthetic lens | 31 | $19,252 | $520 |
| Established patient problem focused exam of visual system | 153 | $11,472 | $42 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 12 | $4,043 | $238 |
| Established patient complete exam of visual system | 64 | $3,927 | $60 |
| Exam of visual field with extended testing | 85 | $2,254 | $22 |
| Imaging of optic nerve | 93 | $1,823 | $18 |
| Return visit (30+ min) | 11 | $792 | $72 |
| Exam of the internal drainage system of eye | 32 | $744 | $17 |
| Ultrasound scan to determine eye length and lens power | 29 | $617 | $21 |
| Imaging of retina | 22 | $454 | $19 |
2022: 11 services
| Removal of cataract with insertion of prosthetic lens | 34 | $20,376 | $522 |
| Complex removal of cataract with insertion of prosthetic lens | 13 | $10,009 | $715 |
| Established patient problem focused exam of visual system | 143 | $9,189 | $39 |
| Established patient complete exam of visual system | 82 | $4,167 | $50 |
| Exam of visual field with extended testing | 112 | $2,838 | $21 |
| Imaging of optic nerve | 113 | $1,743 | $14 |
| Ultrasound scan to determine eye length and lens power | 44 | $975 | $22 |
| Return visit (30+ min) | 12 | $823 | $63 |
| Exam of the internal drainage system of eye | 40 | $813 | $16 |
| Imaging of retina | 34 | $798 | $19 |
| Ct scan of cornea | 12 | $184 | $15 |
2021: 10 services
| Removal of cataract with insertion of prosthetic lens | 41 | $25,442 | $530 |
| Established patient problem focused exam of visual system | 127 | $6,627 | $36 |
| Established patient complete exam of visual system | 72 | $3,344 | $46 |
| Exam of visual field with extended testing | 80 | $2,073 | $22 |
| Return visit (30+ min) | 15 | $1,204 | $80 |
| Imaging of optic nerve | 83 | $1,176 | $14 |
| Exam of the internal drainage system of eye | 33 | $632 | $16 |
| Imaging of retina | 28 | $592 | $18 |
| Ultrasound scan to determine eye length and lens power | 23 | $534 | $22 |
| Measurement of corneal curvature and depth of eye | 19 | $445 | $22 |
2020: 9 services
| Removal of cataract with insertion of prosthetic lens | 18 | $9,319 | $518 |
| Established patient problem focused exam of visual system | 159 | $9,097 | $37 |
| Established patient complete exam of visual system | 51 | $2,589 | $50 |
| Exam of visual field with extended testing | 75 | $1,647 | $20 |
| Imaging of optic nerve | 64 | $1,018 | $15 |
| Telephone medical discussion with physician, 5-10 minutes | 50 | $983 | $19 |
| Imaging of retina | 15 | $373 | $25 |
| Measurement of corneal curvature and depth of eye | 14 | $306 | $19 |
| Exam of the internal drainage system of eye | 15 | $234 | $14 |
2019: 9 services
| Removal of cataract with insertion of prosthetic lens | 37 | $24,299 | $607 |
| Established patient problem focused exam of visual system | 205 | $13,369 | $38 |
| Established patient complete exam of visual system | 93 | $6,033 | $62 |
| Exam of visual field with extended testing | 129 | $3,756 | $22 |
| Imaging of optic nerve | 114 | $2,158 | $18 |
| Return visit (30+ min) | 13 | $721 | $51 |
| Measurement of corneal curvature and depth of eye | 26 | $699 | $26 |
| Imaging of retina | 21 | $469 | $21 |
| Exam of the internal drainage system of eye | 19 | $283 | $15 |
2018: 12 services
| Removal of cataract with insertion of prosthetic lens | 27 | $16,011 | $593 |
| Established patient problem focused exam of visual system | 221 | $15,466 | $41 |
| Complex removal of cataract with insertion of prosthetic lens | 12 | $9,591 | $738 |
| Established patient complete exam of visual system | 106 | $6,613 | $59 |
| Exam of visual field with extended testing | 153 | $4,306 | $23 |
| Imaging of optic nerve | 119 | $2,198 | $17 |
| Return visit (30+ min) | 41 | $1,752 | $37 |
| Measurement of corneal curvature and depth of eye | 38 | $862 | $23 |
| Exam of the internal drainage system of eye | 41 | $684 | $16 |
| New patient complete exam of visual system | 14 | $496 | $35 |
| Imaging of retina | 17 | $393 | $21 |
| Ultrasound scan of cornea to determine thickness | 13 | $73 | $6 |
2017: 13 services
| Removal of cataract with insertion of prosthetic lens | 51 | $31,371 | $581 |
| Established patient problem focused exam of visual system | 180 | $9,528 | $35 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 22 | $6,887 | $222 |
| Established patient complete exam of visual system | 112 | $6,741 | $59 |
| Return visit (30+ min) | 84 | $5,005 | $46 |
| Exam of visual field with extended testing | 106 | $2,305 | $19 |
| Imaging of optic nerve | 99 | $1,708 | $16 |
| Exam of the internal drainage system of eye | 63 | $1,079 | $14 |
| Ultrasound scan to determine eye length and lens power | 16 | $500 | $31 |
| Measurement of corneal curvature and depth of eye | 19 | $456 | $24 |
| Imaging of retina | 17 | $410 | $23 |
| Photography of the retina | 21 | $274 | $13 |
| Ultrasound scan of cornea to determine thickness | 11 | $100 | $9 |
2016: 10 services
| Creation of eye fluid drainage tracts in iris using a laser, per session | 23 | $9,581 | $218 |
| Established patient problem focused exam of visual system | 175 | $9,017 | $35 |
| Return visit (30+ min) | 96 | $6,822 | $53 |
| Established patient complete exam of visual system | 96 | $5,940 | $59 |
| Exam of visual field with extended testing | 151 | $3,618 | $22 |
| Imaging of optic nerve | 147 | $3,290 | $21 |
| Exam of the internal drainage system of eye | 66 | $1,275 | $15 |
| Ultrasound scan to determine eye length and lens power | 34 | $960 | $28 |
| Photography of the retina | 36 | $701 | $19 |
| Imaging of retina | 11 | $214 | $19 |
2015: 8 services
| Removal of cataract with insertion of prosthetic lens | 32 | $17,757 | $555 |
| Established patient complete exam of visual system | 97 | $6,125 | $62 |
| Established patient problem focused exam of visual system | 110 | $5,038 | $37 |
| Imaging of optic nerve | 80 | $1,941 | $22 |
| Exam of visual field with extended testing | 78 | $1,884 | $23 |
| Ultrasound scan to determine eye length and lens power | 29 | $844 | $28 |
| Photography of the retina | 34 | $603 | $18 |
| Exam of the internal drainage system of eye | 24 | $356 | $15 |
2014: 9 services
| Removal of cataract with insertion of prosthetic lens | 32 | $19,324 | $604 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $5,291 | $220 |
| Established patient problem focused exam of visual system | 111 | $4,916 | $38 |
| Established patient complete exam of visual system | 38 | $2,235 | $56 |
| Exam of visual field with extended testing | 80 | $1,798 | $22 |
| Imaging of optic nerve | 70 | $1,526 | $22 |
| Ultrasound scan to determine eye length and lens power | 26 | $635 | $24 |
| Exam of the internal drainage system of eye | 37 | $579 | $15 |
| Photography of the retina | 18 | $313 | $17 |
2013: 11 services
| Removal of cataract with insertion of prosthetic lens | 46 | $30,320 | $606 |
| Established patient problem focused exam of visual system | 252 | $15,394 | $38 |
| Established patient complete exam of visual system | 176 | $10,312 | $57 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 29 | $9,446 | $205 |
| Exam of visual field with extended testing | 229 | $5,116 | $21 |
| Imaging of optic nerve | 173 | $3,674 | $21 |
| Photography of the retina | 84 | $1,432 | $17 |
| Return visit (30+ min) | 21 | $1,277 | $58 |
| Exam of the internal drainage system of eye | 73 | $1,104 | $15 |
| New patient complete exam of visual system | 19 | $1,063 | $56 |
| Ultrasound scan to determine eye length and lens power | 23 | $515 | $21 |
Medicaid work
$16,197 in 2024
Medicaid paid $16,197 for 1,493 billed services this clinician did in 2024, up to 62 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 83 | $10,281 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 571 | $4,167 |
| Service | 28 | $713 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 137 | $517 |
| GONIOSCOPY | 123 | $366 |
| Injection, adrenalin, epinephrine, 0.1 mg | 68 | $70 |
| Cefazolin sodium injection | 53 | $38 |
| Injection, dexamethasone sodium phosphate, 1 mg | 58 | $35 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 14 | $9 |
| Service | 358 | $0 |
| 2024 | 1,493 | 10 | 62 | $16,197 |
| 2023 | 1,831 | 11 | 59 | $8,301 |
| 2022 | 1,031 | 6 | 46 | $4,344 |
| 2021 | 388 | 5 | 42 | $4,955 |
| 2020 | 607 | 4 | 61 | $3,933 |
| 2019 | 954 | 5 | 69 | $6,210 |
| 2018 | 1,586 | 15 | 69 | $10,148 |
See the largest Medicaid services in earlier years
2023
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 27 | $3,267 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 582 | $2,801 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 276 | $853 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 229 | $625 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 95 | $375 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 41 | $198 |
| GONIOSCOPY | 75 | $160 |
| Injection, dexamethasone sodium phosphate, 1 mg | 70 | $16 |
| Cefazolin sodium injection | 42 | $6 |
| Service | 354 | $0 |
| Injection, adrenalin, epinephrine, 0.1 mg | 40 | $0 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 440 | $2,567 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 242 | $651 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 200 | $586 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 27 | $286 |
| GONIOSCOPY | 77 | $155 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 45 | $99 |
2021
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $3,076 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 113 | $984 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 114 | $386 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 135 | $307 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 14 | $202 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 433 | $3,243 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 72 | $329 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 75 | $304 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 27 | $56 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 568 | $2,616 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $2,328 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 156 | $533 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 167 | $471 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 51 | $263 |
2018
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 26 | $5,254 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 606 | $2,655 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 295 | $652 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 197 | $585 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 89 | $454 |
| Return visit (30+ min) | 35 | $194 |
| Service | 17 | $146 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 26 | $105 |
| Service | 28 | $52 |
| Blood glucose (sugar) level | 15 | $20 |
| GONIOSCOPY | 12 | $17 |
| Injection, adrenalin, epinephrine, 0.1 mg | 15 | $9 |
Drugs they prescribed that Part D paid
$205,178
Pharmacies billed $205,178 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,158) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,443 generic and 715 brand-name prescriptions · $205,178 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rhopressa | 138 | $49,907 | $362 |
| Lumigan | 111 | $42,337 | $381 |
| Vyzulta | 86 | $27,327 | $318 |
| Brimonidine | 306 | $23,250 | $76 |
| Alphagan P | 16 | $9,320 | $583 |
See all 16 drugs
| Rhopressa | 138 | $49,907 | $362 |
| Lumigan | 111 | $42,337 | $381 |
| Vyzulta | 86 | $27,327 | $318 |
| Brimonidine | 306 | $23,250 | $76 |
| Alphagan P | 16 | $9,320 | $583 |
| Prednisolone Acetate | 157 | $7,174 | $46 |
| Latanoprost | 503 | $5,900 | $12 |
| Azopt | 11 | $5,222 | $475 |
| Travoprost | 33 | $4,093 | $124 |
| Dorzolamide-Timolol | 224 | $3,776 | $17 |
| Dorzolamide | 171 | $2,919 | $17 |
| Timolol Maleate | 262 | $2,890 | $11 |
| Brimonidine Tartrate-Timolol | 11 | $1,910 | $174 |
| Atropine Sulfate | 16 | $527 | $33 |
| Pilocarpine | 11 | $461 | $42 |
| Moxifloxacin | 14 | $223 | $16 |
Year by year
| 2024 | 2,158 | 301 | 0% (0) | 33% | $205,178 |
| 2023 | 2,063 | 289 | 0% (0) | 36% | $265,509 |
| 2022 | 2,020 | 299 | 0% (0) | 35% | $230,767 |
| 2021 | 2,045 | 302 | 0% (0) | 39% | $222,327 |
| 2020 | 1,997 | 251 | 0% (0) | 35% | $250,632 |
| 2019 | 1,985 | 271 | 0% (0) | 32% | $242,393 |
| 2018 | 2,281 | 329 | 0% (0) | 35% | $236,940 |
| 2017 | 2,573 | 338 | 0% (0) | 39% | $230,845 |
| 2016 | 2,417 | 319 | 0% (0) | 42% | $217,393 |
| 2015 | 1,734 | 289 | 0% (0) | None | $149,857 |
| 2014 | 1,309 | 254 | None | None | $114,686 |
| 2013 | 1,633 | 249 | 0% (0) | 44% | $140,636 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Rhopressa | 156 | $61,169 | $392 |
| Lumigan | 114 | $46,706 | $410 |
| Alphagan P | 39 | $25,980 | $666 |
| Vyzulta | 85 | $23,889 | $281 |
| Brimonidine | 212 | $21,805 | $103 |
| Restasis | 24 | $13,733 | $572 |
| Travoprost | 47 | $9,835 | $209 |
| Latanoprost | 463 | $9,072 | $20 |
| Prednisolone Acetate | 133 | $7,787 | $59 |
| Dorzolamide | 188 | $7,365 | $39 |
| Azopt | 14 | $7,220 | $516 |
| Dorzolamide-Timolol | 217 | $6,980 | $32 |
| Brimonidine Tartrate-Timolol | 12 | $4,563 | $380 |
| Timolol Maleate | 270 | $4,278 | $16 |
| Pilocarpine | 12 | $942 | $78 |
| Atropine Sulfate | 12 | $526 | $44 |
| Moxifloxacin | 12 | $414 | $35 |
2022: 16 drugs
| Rhopressa | 119 | $38,947 | $327 |
| Lumigan | 110 | $38,701 | $352 |
| Alphagan P | 37 | $25,378 | $686 |
| Brimonidine | 235 | $24,196 | $103 |
| Vyzulta | 80 | $18,902 | $236 |
| Travoprost | 42 | $12,679 | $302 |
| Dorzolamide | 218 | $10,028 | $46 |
| Restasis | 16 | $8,943 | $559 |
| Latanoprost | 405 | $8,660 | $21 |
| Prednisolone Acetate | 135 | $8,060 | $60 |
| Dorzolamide-Timolol | 191 | $5,188 | $27 |
| Timolol Maleate | 313 | $5,004 | $16 |
| Simbrinza | 17 | $3,646 | $214 |
| Moxifloxacin | 25 | $906 | $36 |
| Atropine Sulfate | 11 | $532 | $48 |
| Ketorolac Tromethamine | 12 | $190 | $16 |
2021: 16 drugs
| Lumigan | 96 | $29,462 | $307 |
| Alphagan P | 43 | $23,371 | $544 |
| Rhopressa | 80 | $22,682 | $284 |
| Vyzulta | 94 | $21,497 | $229 |
| Brimonidine | 221 | $21,040 | $95 |
| Restasis | 34 | $15,606 | $459 |
| Travoprost | 50 | $14,865 | $297 |
| Prednisolone Acetate | 168 | $10,456 | $62 |
| Dorzolamide | 219 | $9,470 | $43 |
| Latanoprost | 412 | $9,247 | $22 |
| Azopt | 12 | $8,096 | $675 |
| Combigan | 13 | $7,578 | $583 |
| Dorzolamide-Timolol | 201 | $5,523 | $27 |
| Zioptan | 19 | $5,135 | $270 |
| Timolol Maleate | 309 | $4,813 | $16 |
| Moxifloxacin | 11 | $310 | $28 |
2020: 17 drugs
| Brimonidine | 209 | $25,243 | $121 |
| Alphagan P | 50 | $24,680 | $494 |
| Rhopressa | 88 | $24,573 | $279 |
| Lumigan | 71 | $24,340 | $343 |
| Restasis | 58 | $23,972 | $413 |
| Vyzulta | 97 | $20,981 | $216 |
| Travatan Z | 26 | $15,046 | $579 |
| Azopt | 21 | $12,980 | $618 |
| Dorzolamide | 243 | $11,016 | $45 |
| Travoprost | 40 | $10,984 | $275 |
| Latanoprost | 413 | $9,787 | $24 |
| Combigan | 17 | $9,583 | $564 |
| Methazolamide | 12 | $9,414 | $785 |
| Dorzolamide-Timolol | 198 | $7,645 | $39 |
| Zioptan | 17 | $7,497 | $441 |
| Prednisolone Acetate | 70 | $5,134 | $73 |
| Timolol Maleate | 310 | $4,023 | $13 |
2019: 16 drugs
| Travatan Z | 73 | $31,364 | $430 |
| Alphagan P | 55 | $29,593 | $538 |
| Lumigan | 70 | $28,299 | $404 |
| Brimonidine | 209 | $26,827 | $128 |
| Rhopressa | 69 | $22,627 | $328 |
| Azopt | 39 | $17,375 | $446 |
| Restasis | 36 | $15,458 | $429 |
| Dorzolamide | 265 | $10,993 | $41 |
| Vyzulta | 49 | $10,714 | $219 |
| Latanoprost | 471 | $10,569 | $22 |
| Zioptan | 18 | $7,300 | $406 |
| Combigan | 12 | $6,931 | $578 |
| Dorzolamide-Timolol | 115 | $5,196 | $45 |
| Prednisolone Acetate | 63 | $4,395 | $70 |
| Timolol Maleate | 374 | $3,842 | $10 |
| Pilocarpine | 13 | $954 | $73 |
2018: 14 drugs
| Travatan Z | 131 | $43,246 | $330 |
| Brimonidine | 250 | $33,555 | $134 |
| Lumigan | 88 | $32,033 | $364 |
| Alphagan P | 57 | $28,047 | $492 |
| Azopt | 67 | $26,628 | $397 |
| Restasis | 43 | $17,578 | $409 |
| Latanoprost | 570 | $10,928 | $19 |
| Dorzolamide | 289 | $8,103 | $28 |
| Prednisolone Acetate | 124 | $7,914 | $64 |
| Zioptan | 19 | $6,196 | $326 |
| Timolol Maleate | 473 | $4,346 | $9 |
| Olopatadine | 13 | $1,476 | $114 |
| Dorzolamide-Timolol | 70 | $1,453 | $21 |
| Pilocarpine | 17 | $1,299 | $76 |
2017: 16 drugs
| Brimonidine | 303 | $56,895 | $188 |
| Travatan Z | 210 | $46,283 | $220 |
| Lumigan | 90 | $27,908 | $310 |
| Alphagan P | 50 | $20,574 | $411 |
| Azopt | 39 | $12,682 | $325 |
| Prednisolone Acetate | 173 | $11,698 | $68 |
| Dorzolamide | 405 | $11,168 | $28 |
| Latanoprost | 558 | $10,350 | $19 |
| Restasis | 29 | $8,506 | $293 |
| Combigan | 27 | $5,540 | $205 |
| Pataday | 21 | $4,472 | $213 |
| Timolol Maleate | 492 | $4,412 | $9 |
| Pilocarpine | 16 | $1,231 | $77 |
| Dorzolamide-Timolol | 57 | $1,066 | $19 |
| Ketorolac Tromethamine | 20 | $1,022 | $51 |
| Atropine Sulfate | 15 | $663 | $44 |
2016: 15 drugs
| Brimonidine | 336 | $61,959 | $184 |
| Travatan Z | 227 | $50,324 | $222 |
| Alphagan P | 65 | $22,160 | $341 |
| Lumigan | 66 | $19,216 | $291 |
| Dorzolamide | 381 | $10,787 | $28 |
| Azopt | 31 | $8,493 | $274 |
| Prednisolone Acetate | 133 | $8,439 | $63 |
| Latanoprost | 487 | $7,911 | $16 |
| Combigan | 30 | $5,599 | $187 |
| Restasis | 19 | $3,906 | $206 |
| Timolol Maleate | 435 | $3,429 | $8 |
| Dorzolamide-Timolol | 91 | $2,155 | $24 |
| Pilocarpine | 21 | $1,642 | $78 |
| Atropine Sulfate | 13 | $567 | $44 |
| Ketorolac Tromethamine | 11 | $491 | $45 |
2015: 12 drugs
| Travatan Z | 210 | $44,824 | $213 |
| Brimonidine | 217 | $33,987 | $157 |
| Alphagan P | 67 | $15,434 | $230 |
| Lumigan | 55 | $10,762 | $196 |
| Dorzolamide | 265 | $8,146 | $31 |
| Prednisolone Acetate | 143 | $8,019 | $56 |
| Latanoprost | 286 | $5,478 | $19 |
| Restasis | 17 | $3,560 | $209 |
| Timolol Maleate | 313 | $3,001 | $10 |
| Combigan | 17 | $2,940 | $173 |
| Acetazolamide | 11 | $1,679 | $153 |
| Dorzolamide-Timolol | 49 | $1,303 | $27 |
2014: 10 drugs
| Travatan Z | 150 | $33,548 | $224 |
| Brimonidine | 152 | $20,065 | $132 |
| Alphagan P | 56 | $13,035 | $233 |
| Lumigan | 45 | $10,657 | $237 |
| Dorzolamide | 228 | $8,058 | $35 |
| Prednisolone Acetate | 109 | $7,258 | $67 |
| Latanoprost | 198 | $4,548 | $23 |
| Timolol Maleate | 236 | $2,822 | $12 |
| Dorzolamide-Timolol | 38 | $1,180 | $31 |
| Cosopt Pf | 11 | $970 | $88 |
2013: 11 drugs
| Travatan Z | 270 | $51,151 | $189 |
| Brimonidine | 168 | $27,774 | $165 |
| Dorzolamide | 306 | $15,867 | $52 |
| Alphagan P | 54 | $15,155 | $281 |
| Lumigan | 47 | $8,654 | $184 |
| Latanoprost | 317 | $7,637 | $24 |
| Timolol Maleate | 311 | $4,059 | $13 |
| Pataday | 14 | $1,767 | $126 |
| Prednisolone Acetate | 67 | $1,641 | $24 |
| Azopt | 12 | $1,552 | $129 |
| Xalatan | 12 | $1,187 | $99 |
Money from drug and device companies
$124 in 2019
A payment is not proof that care is biased.
See all 2 published payments
| Allergan | Meals · 2019-03-14 | Xen | $50 |
| Glaukos | Meals · 2019-03-11 | Istent Inject Trabecular Micro-Bypass Stent System | $74 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1528155835
- Licence
- CA A80220California A80220: Current · expires 2028-02-29
- Trained
- Un of California, Irvine, College of Medicine, 2001
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 751 S Bascom Ave, Building Q, San Jose, CA, 95128
- NPI first listed
- 2006-10-06
- NPI last updated
- 2012-02-27
This is when the NPI record was last certified, not a medical board exam.